- 收听数
- 0
- 听众数
- 5
- 最后登录
- 2021-7-9
- QQ
- UID
- 9301
- 阅读权限
- 10
- 帖子
- 1184
- 精华
- 0
- 在线时间
- 378 小时
- 注册时间
- 2014-5-1
- 科研币
- 2
- 速递币
- 39
- 娱乐币
- 1715
- 文献值
- 0
- 资源值
- 0
- 贡献值
- 0
|
10速递币
题名 | ZD1839, a selective oral epidermal growth factor receptor-tyrosine kinase inhibitor, is well tolerated and active in patients with solid, malignant tumors: results of a phase I trial. | 链接 | http://jco.ascopubs.org/content/20/9/2240.long |
|
|